RxDoctor Payments Data

Jason Freedman, MD

Orthopaedic Surgery · Cambridge, MANPI 1710100854

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (41.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Kairos Surgical Inc at 46.5% of the total. Reporting peaked in 2021 at $1,235 and has fallen 96.1% since, to $48 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in MA, where the typical reported total is $3,637.

$2,887in general payments, 2019–2025

Across 18 payments — averaging $160.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kairos Surgical Inc$1K
  • Cardinal Health 200 LLC$575
  • Innovation Technologies Inc$226
  • Miach Orthopaedics, Inc.$144
  • Novartis$117
  • My01 Inc.$108
  • plus $374 from 8 others

What the payments were for

  • Consulting fees$57520%
  • Food & beverage$1,11239%
  • Education$1,20042%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,887 in reported general payments places this provider in the 45th percentile of 542 orthopaedic surgery providers in Massachusetts.

See all orthopaedic surgery providers in Massachusetts →

Medicare billing

Part B allowed, 2024
$34,886
Medicare patients
135
Services billed
253

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium11$244

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Cambridge

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →